~~<i id='0A303BB621'><strike id='0A303BB621'><tt id='0A303BB621'><pre id='0A303BB621'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：leisure time 2025-09-29 08:01:25 Page View：6715

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： White House drug shortages task force keeps mum with Congress
Next article： Walensky prepares to leave CDC — and Congress — behind

comprehensive

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Eyeing GLP

AdobeDigitaltherapeuticscompanyClickTherapeuticsannouncedWednesdayitwillacquiretheassetsofBetterTher

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

H5N1 bird flu outbreak: Second human case reported, in Michigan

MicroscopicimageofH5N1avianinfluenzavirusparticles(inorange).CDCandNIAIDAsecondhumancaseofH5N1birdfl